AKYA vs. QSI, QTRX, MASS, FEIM, SEER, RPID, KEQU, NAUT, ODYS, and INTT
Should you be buying Akoya Biosciences stock or one of its competitors? The main competitors of Akoya Biosciences include Quantum-Si (QSI), Quanterix (QTRX), 908 Devices (MASS), Frequency Electronics (FEIM), Seer (SEER), Rapid Micro Biosystems (RPID), Kewaunee Scientific (KEQU), Nautilus Biotechnology (NAUT), Odysight.Ai (ODYS), and inTEST (INTT). These companies are all part of the "measuring and control equipment" industry.
Akoya Biosciences vs.
Akoya Biosciences (NASDAQ:AKYA) and Quantum-Si (NASDAQ:QSI) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, profitability, dividends, analyst recommendations, earnings, community ranking, institutional ownership, media sentiment and risk.
Akoya Biosciences presently has a consensus target price of $3.21, suggesting a potential upside of 165.15%. Quantum-Si has a consensus target price of $3.48, suggesting a potential upside of 199.57%. Given Quantum-Si's stronger consensus rating and higher probable upside, analysts clearly believe Quantum-Si is more favorable than Akoya Biosciences.
Akoya Biosciences received 26 more outperform votes than Quantum-Si when rated by MarketBeat users. However, 69.23% of users gave Quantum-Si an outperform vote while only 56.45% of users gave Akoya Biosciences an outperform vote.
Akoya Biosciences has a net margin of -66.77% compared to Quantum-Si's net margin of -3,968.84%. Quantum-Si's return on equity of -36.96% beat Akoya Biosciences' return on equity.
Akoya Biosciences has higher revenue and earnings than Quantum-Si. Quantum-Si is trading at a lower price-to-earnings ratio than Akoya Biosciences, indicating that it is currently the more affordable of the two stocks.
79.4% of Akoya Biosciences shares are owned by institutional investors. Comparatively, 39.9% of Quantum-Si shares are owned by institutional investors. 7.3% of Akoya Biosciences shares are owned by company insiders. Comparatively, 30.0% of Quantum-Si shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
In the previous week, Akoya Biosciences had 3 more articles in the media than Quantum-Si. MarketBeat recorded 6 mentions for Akoya Biosciences and 3 mentions for Quantum-Si. Quantum-Si's average media sentiment score of 0.91 beat Akoya Biosciences' score of -0.28 indicating that Quantum-Si is being referred to more favorably in the news media.
Akoya Biosciences has a beta of 1.33, meaning that its share price is 33% more volatile than the S&P 500. Comparatively, Quantum-Si has a beta of 2.71, meaning that its share price is 171% more volatile than the S&P 500.
Summary
Quantum-Si beats Akoya Biosciences on 10 of the 18 factors compared between the two stocks.
Get Akoya Biosciences News Delivered to You Automatically
Sign up to receive the latest news and ratings for AKYA and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Akoya Biosciences Competitors List
Related Companies and Tools
This page (NASDAQ:AKYA) was last updated on 5/1/2025 by MarketBeat.com Staff
Buy AKYA Stock Free AKYA Stock Alerts